Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Sistigu

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Oncogene|August 21, 2023
Epigenetics behind tumor immunology: a mini reviewMartina Musella, Nicoletta Manduca, Ester Maccafeo, et al.
Molecular & Cellular Oncology|June 17, 2016
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyGwenola Manic, Florine Obrist, Antonella Sistigu, et al.
Molecular & Cellular Oncology|June 17, 2016
Trial watch - inhibiting PARP enzymes for anticancer therapyAntonella Sistigu, Gwenola Manic, Florine Obrist, et al.
Biology|September 28, 2021
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune ActivationMartina Musella, Claudia Galassi, Nicoletta Manduca, et al.
Cytokine & Growth Factor Reviews|July 12, 2017
The added value of type I interferons to cytotoxic treatments of cancerLaura Bracci, Antonella Sistigu, Enrico Proietti, et al.
Cytokine & Growth Factor Reviews|June 10, 2017
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoeditingAntonella Sistigu, Francesca Di Modugno, Gwenola Manic, et al.
The Journal of General Virology|July 24, 2009
Human immunodeficiency virus type 1 (HIV-1) protease inhibitors block cell-to-cell HIV-1 endocytosis in dendritic cellsClaudia Muratori, Eliana Ruggiero, Antonella Sistigu, et al.
Cells|September 28, 2021
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy FailureClaudia Galassi, Martina Musella, Nicoletta Manduca, et al.
Methods in Enzymology|January 18, 2020
Assessment of IFN-γ and granzyme-B production by in "sitro" technologyClaudia Galassi, Gwenola Manic, Martina Musella, et al.
Methods in Enzymology|February 1, 2020
Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodiesMartina Musella, Gwenola Manic, Claudia Galassi, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Oncogene|August 21, 2023
Epigenetics behind tumor immunology: a mini reviewMartina Musella, Nicoletta Manduca, Ester Maccafeo, et al.
Molecular & Cellular Oncology|June 17, 2016
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyGwenola Manic, Florine Obrist, Antonella Sistigu, et al.
Molecular & Cellular Oncology|June 17, 2016
Trial watch - inhibiting PARP enzymes for anticancer therapyAntonella Sistigu, Gwenola Manic, Florine Obrist, et al.
Biology|September 28, 2021
The Yin and Yang of Type I IFNs in Cancer Promotion and Immune ActivationMartina Musella, Claudia Galassi, Nicoletta Manduca, et al.
Cytokine & Growth Factor Reviews|July 12, 2017
The added value of type I interferons to cytotoxic treatments of cancerLaura Bracci, Antonella Sistigu, Enrico Proietti, et al.
Cytokine & Growth Factor Reviews|June 10, 2017
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoeditingAntonella Sistigu, Francesca Di Modugno, Gwenola Manic, et al.
The Journal of General Virology|July 24, 2009
Human immunodeficiency virus type 1 (HIV-1) protease inhibitors block cell-to-cell HIV-1 endocytosis in dendritic cellsClaudia Muratori, Eliana Ruggiero, Antonella Sistigu, et al.
Cells|September 28, 2021
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy FailureClaudia Galassi, Martina Musella, Nicoletta Manduca, et al.
Methods in Enzymology|January 18, 2020
Assessment of IFN-γ and granzyme-B production by in "sitro" technologyClaudia Galassi, Gwenola Manic, Martina Musella, et al.
Methods in Enzymology|February 1, 2020
Cytofluorometric assessment of dendritic cell-mediated uptake of cancer cell apoptotic bodiesMartina Musella, Gwenola Manic, Claudia Galassi, et al.
Pageof 5